AbCellera Biologics Inc. (ABCL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.02B |
| Enterprise Value | 1.04B |
| P/E Ratio | -24.9 |
| PEG Ratio | -1.71 |
| Price/Sales Ratio | 57.52 |
| Price/Book Ratio | 3.58 |
| Enterprise/Revenue | 57.08 |
| Enterprise/EBITDA | -27.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -2.19 |
| Operating Margin | -2.98 |
| Return On Assets | -0.1 |
| Return On Equity | -0.15 |
| Revenue | 75.13M |
| Revenue/Share | 0.21 |
| Gross Profit | 46.31M |
| EBITDA | -148.77M |
| Net Income | -146.41M |
| Diluted EPS | -0.49 |
| Total Cash | 764.42M |
| Total Cash/Share | 2.4 |
| Total Debt | 133.82M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 12.43 |
| Book Value Per Share | 3.34 |
| 52-Week Change | 198 |
| 52-Week High | 15.02 |
| 52-Week Low | 2.75 |
| Moving Average 50 Days | 12.32 |
| Moving Average 200 Days | 7.12 |
| Average Volume | 5.31M |
| Shares Outstanding | 326.62M |
| % Held by Institutions | 38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |